Navigation Links
ERT to Present at the 29th Annual J.P. Morgan Healthcare Conference on January 13, 2011
Date:1/4/2011

PHILADELPHIA, Jan. 4, 2011 /PRNewswire/ -- ERT (Nasdaq: ERES), announced today that Dr. Joel Morganroth, the Company's Chairman and CEO, and Keith Schneck, the Company's Chief Financial Officer, are scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference at 9:30 AM PST on January 13, 2011 in San Francisco, California.

Interested parties may access the presentation by visiting the Company's corporate website at http://www.ert.com. The webcast may also be accessed at http://jpmorgan.metameetings.com/webcasts/healthcare11/directlink?ticker=ERES.  The webcast will be available via replay for 90 days.

About ERT

Based in Philadelphia, PA, eResearchTechnology, Inc. (www.ert.com) is a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. It is also a leading provider of centralized respiratory technology and services to evaluate pulmonary function efficacy and safety in clinical development. Sponsors can further use the Company's solutions to streamline the clinical trials process by automating the collection, analysis, and distribution of ePRO clinical data using multi-mode technology in all phases of clinical development as well as selected medical devices for the clinical trials and healthcare industries.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope, and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endo to Present at the J.P. Morgan 29th Annual Healthcare Conference
2. Warner Chilcott to Present at the 29th Annual J.P. Morgan Healthcare Conference
3. NxStage to Present at the 29th Annual J.P. Morgan Healthcare Conference
4. ADVENTRX Pharmaceuticals to Present at the 4TH Annual OneMedForum Business Development and Investment Conference on January 11
5. Syndax Pharmaceuticals to Present at Biotech Showcase 2011
6. PAREXEL International to Present at J.P. Morgan Healthcare Conference
7. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
8. Medco CEO to Present at Upcoming Healthcare Conferences
9. Misonix to Present at Sidoti & Company 2011 Micro Cap Conference
10. Bacterin International Holdings to Present at the OneMedForum San Francisco 2011
11. Express Scripts to Present at the J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... , May 20, 2016 ... Pipeline Review, H1 2016" market research report with ... Psoriasis (Psoriasis Vulgaris), complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ...
(Date:5/19/2016)... -- A new report published by Allied ... Forecasts, 2015 -2022, projects that the world medical imaging ... CAGR of 5.1% from 2015 to 2022. X-ray imaging ... revenue-generating segment throughout the forecast period. North ... market share in 2015, and is expected to dominate ...
(Date:5/19/2016)... , May 19, 2016 The equities ... is always abounding of surprises is without doubt the Healthcare ... ahead of today,s trading session: Alkermes PLC (NASDAQ: ... IDEXX Laboratories Inc. (NASDAQ: IDXX ), and Atossa ... your complimentary alerts at: http://www.activewallst.com/ ...
Breaking Medicine Technology:
(Date:5/24/2016)... Angeles, California (PRWEB) , ... May 24, 2016 , ... ... $4,000, food, clothing, supplies and other necessities to Eunime Orphanage in Tijuana, Mexico on ... pizza and play games at Peter Piper Pizza. , More than 15 volunteers ...
(Date:5/24/2016)... ... May 24, 2016 , ... Global Lyme Alliance ... today announced that it has named Scott Santarella as its new CEO. ... Cancer Foundation (ALCF) in San Francisco, where he successfully helped to grow the ...
(Date:5/24/2016)... ... May 24, 2016 , ... PhysicianOne Urgent Care, advocators in helping their patients ... how to avoid being bitten this spring. , The official tick season kicks ... spider-like insects, are known for attaching themselves to their prey while they feed off ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... high content imaging; multiplex immunoassays are widely used for cell and protein analysis. ... to maximize their quality and efficiency in these areas. , LabRoots introduces a ...
(Date:5/23/2016)... ... ... On the occasion of his 25th Anniversary of changing and saving people's lives, ... patients have a consultation and evaluation (done by Dr. Ferdico personally). Then the patient ... There are 15 things that each patient gets checked for, ...
Breaking Medicine News(10 mins):